Degradation Testing of Oral Absorbable Biomaterials: Standards, Methods, and Applications

Degradation testing of oral absorbable materials is a critical step in evaluating the safety, performance, and regulatory compliance of resorbable dental products such as bone graft substitutes, collagen membranes, and absorbable sutures. By simulating physiological and accelerated degradation environments in accordance with ISO 10993-13, ISO 10993-14, and ASTM F1635, accredited third-party laboratories can characterize mass loss, molecular weight decline, degradation product release, and mechanical property retention throughout the material's service life. This article provides a comprehensive technical overview of sample types, testing items, analytical methods, and typical applications for degradation testing of absorbable biomaterials used in oral and dental applications.

Technical Overview

Absorbable (bioresorbable) materials are widely used in modern dentistry and oral surgery because they perform a temporary therapeutic function—such as space maintenance, barrier protection, or mechanical support—and are gradually broken down and metabolized or excreted by the body, eliminating the need for a second removal surgery. Common examples include guided bone regeneration (GBR) and guided tissue regeneration (GTR) membranes, collagen-based scaffolds, calcium phosphate bone graft substitutes, and absorbable fixation devices used in orthognathic and maxillofacial procedures.

Degradation testing evaluates how these materials break down over time under simulated physiological conditions, and whether the degradation process and its products remain biologically acceptable. Because degradation directly governs the functional lifetime of the device, the release rate of degradation products, and the local pH environment in hard-to-flush tissue sites such as extraction sockets and periodontal defects, regulatory authorities worldwide expect degradation data as part of the biological safety evaluation.

The principal framework for degradation testing is built on the ISO 10993 family of standards:

• ISO 10993-1 — Biological evaluation of medical devices: evaluation and testing within a risk management process, which identifies degradation as an essential component of the safety assessment.
• ISO 10993-13 — Identification and quantification of degradation products from polymeric medical devices, covering both real-time and accelerated in vitro degradation.
• ISO 10993-14 — Identification and quantification of degradation products from ceramics, which specifies dissolution testing under neutral and extreme pH conditions.
• ISO 10993-15 — Identification and quantification of degradation products from metals and alloys, applicable to metal-containing composite devices.
• ISO 10993-6 — Tests for local effects after implantation, frequently used to confirm in vivo degradation behavior and tissue response.
• ISO 10993-9 — Framework for identification and quantification of potential degradation products.
• ISO 10993-17 — Toxicological risk assessment, used to evaluate the safety of quantified degradation products.

Additional material-specific references include ASTM F1635 (in vitro degradation of polymeric resorbable devices), ASTM F2902 (guide for assessment of absorbable medical devices), ISO 15814 (degradation of polymers based on polylactides and lactide/glycolide copolymers for surgical implants), ISO 13779 (hydroxyapatite ceramics), and the GB/T 16886 series, which is the Chinese national adoption of ISO 10993 commonly referenced for NMPA submissions.

Testing Samples

Degradation testing programs are designed according to the chemical nature and intended function of the absorbable material. The major categories relevant to oral and dental applications are described below.

Synthetic Aliphatic Polyesters

Synthetic polymers such as poly(L-lactic acid) (PLLA), polyglycolide (PGA), poly(lactide-co-glycolide) (PLGA), polycaprolactone (PCL), and polydioxanone (PDO) are used in resorbable membranes, scaffolds, films, and fixation screws and plates. These materials degrade primarily through hydrolytic chain scission, resulting in a progressive reduction in molecular weight, loss of mechanical integrity, and release of lactic and glycolic acid monomers and oligomers.

Natural Polymers and Protein-Based Materials

Collagen (porcine, bovine, or fish-derived), gelatin, chitosan, alginate, and hyaluronic acid are widely used in dental barrier membranes and wound dressings. These materials degrade enzymatically, so in vitro testing often incorporates relevant enzymes such as collagenase or lysozyme in addition to buffered media to better approximate in vivo conditions.

Ceramic and Inorganic Materials

Hydroxyapatite (HA), beta-tricalcium phosphate (β-TCP), biphasic calcium phosphate (BCP) mixtures, calcium sulfate, bioactive glasses, and calcium phosphate cements are used as bone graft substitutes and graft extenders. Their degradation occurs through dissolution and cell-mediated resorption, releasing calcium, phosphate, and other ions into the surrounding environment.

Composite and Hybrid Materials

Many modern dental products combine a polymeric matrix with ceramic fillers—for example, collagen membranes loaded with hydroxyapatite particles, or PLGA scaffolds reinforced with bioactive glass. Composite degradation testing must address both the hydrolytic or enzymatic breakdown of the matrix and the dissolution of the inorganic phase.

Finished Product Forms

• GBR and GTR barrier membranes (collagen-based or synthetic)
• Bone graft substitutes and granules in various particle sizes
• Absorbable sutures and ligatures used in oral surgery
• Resorbable pins, screws, plates, and meshes for maxillofacial fixation
• Scaffolds and matrices for dental pulp and periodontal tissue engineering
• Absorbable drug delivery carriers for local release in periodontal pockets

Testing may be performed on the final finished device in its sterilized, packaged condition whenever possible, since sterilization method (ethylene oxide, gamma irradiation, e-beam) can significantly alter degradation kinetics and initial molecular weight.

Testing Items

A comprehensive degradation study characterizes the material at multiple incubation time points across the anticipated degradation profile. Core testing items include:

• Mass change and mass loss — gravimetric determination of dry mass reduction over time, expressed as a percentage of the initial mass.
• Water uptake and swelling ratio — quantification of fluid absorption, which is particularly relevant for membranes and hydrogels that must maintain barrier function.
• Molecular weight evolution — measurement of weight-average molecular weight (Mw), number-average molecular weight (Mn), and dispersity by gel permeation chromatography (GPC/SEC), or inherent/intrinsic viscosity for polymers such as sutures.
• Monomer and oligomer release — quantification of lactic acid, glycolic acid, lactide, glycolide, and soluble oligomers in the degradation medium using HPLC, LC-MS, or GC-MS.
• Ionic degradation products — measurement of calcium, phosphate, silicate, and other released ions by ICP-OES, ICP-MS, or ion chromatography for ceramic and composite materials.
• pH monitoring — tracking of medium acidification, an important indicator of local biological impact since acid accumulation can irritate surrounding bone and soft tissue.
• Mechanical property retention — tensile strength, elongation, burst strength, suture pull-out strength, or flexural strength measured at each time point to define the functional lifetime of the device.
• Morphological assessment — surface and cross-sectional imaging by scanning electron microscopy (SEM) to observe erosion patterns, cracking, pore opening, and bulk disintegration.
• Crystallinity and thermal properties — DSC, TGA, and XRD analysis to track changes in glass transition temperature, melting behavior, and crystalline content that accompany polymer chain scission or ceramic phase transformation.
• Dimensional stability — changes in specimen dimensions, thickness, volume, and shape over the degradation period.
• Residual mass and fragmentation — identification and quantification of any non-degraded fragments or particulates at late time points.
• Cytotoxicity of degradation products — evaluation of degradation extracts according to ISO 10993-5 to confirm that accumulated products do not produce unacceptable biological effects.
• In vivo degradation confirmation — histological assessment of implant sites per ISO 10993-6 to correlate in vitro findings with actual resorption and tissue response in animal models.

Testing Methods

Real-Time In Vitro Degradation

Specimens are incubated in a defined aqueous medium at physiological temperature (37 °C ± 1 °C) under controlled conditions for a period spanning the intended functional lifetime of the device and, where practical, through complete resorption. ISO 10993-13 specifies the use of a medium with a pH and ionic composition appropriate to the clinical environment, with a sufficiently large solution volume-to-sample mass ratio to avoid saturation. Common media include phosphate-buffered saline (PBS, pH 7.4), Tris-HCl buffer, simulated body fluid (SBF), artificial saliva, and, for enzymatically degraded materials, buffered enzyme solutions such as collagenase-containing media for collagen membranes.

Accelerated In Vitro Degradation

Because full resorption of some oral materials may require months or years, accelerated testing at elevated temperatures (for example, 50 °C, 60 °C, or 70 °C) is used to shorten the study duration. ISO 10993-13 requires that the accelerated condition be justified, that degradation mechanisms remain identical to those at 37 °C, and that a correlation between accelerated and real-time data be established or acknowledged as a limitation. The Arrhenius relationship is typically used to estimate the temperature dependence of hydrolytic degradation rates.

Extreme pH Testing for Ceramics

In accordance with ISO 10993-14, ceramic bone graft materials are subjected to dissolution testing under strongly acidic (approximately pH 3) and strongly alkaline (approximately pH 10) conditions using hydrochloric acid and sodium hydroxide solutions, in addition to a neutral reference solution. This approach brackets the range of possible in vivo environments and identifies the elements released under worst-case conditions.

Test Protocol Design

• Specimens are tested in their final form, or as representative coupons when whole devices cannot be accommodated, with a minimum of three to five replicates per time point.
• Time points are selected to capture the early, intermediate, and late phases of degradation—for example, 1, 2, 4, 8, 12, 26, and 52 weeks, adjusted to the expected material lifetime.
• Control (blank) media vessels are maintained under identical conditions to account for background contamination and evaporation effects.
• Media are collected and replaced at defined intervals for analytical testing, and total ion or monomer release is calculated by mass balance across all collection points.
• At each time point, specimens are retrieved, gently cleaned, dried to constant mass under defined conditions, and subjected to gravimetric, mechanical, chromatographic, spectroscopic, and microscopic characterization.
• Sterility, container closure integrity, and the effect of the sterilization method on initial properties are documented as part of the study design.

Analytical Workflow and Data Interpretation

The analytical sequence typically proceeds from non-destructive observations (visual inspection, dimensional measurement, imaging) through gravimetric and mechanical testing to destructive chemical analysis (GPC, HPLC/LC-MS, ICP-MS, DSC, XRD). Results are presented as degradation profiles—property value versus time—which allow determination of the degradation half-life, the time to loss of mechanical functionality, and the total burden of degradation products. These data feed directly into the toxicological risk assessment under ISO 10993-17 and the overall biological evaluation plan under ISO 10993-1.

Applications

Degradation testing of oral absorbable materials supports product development, quality control, and regulatory clearance across a wide range of dental clinical scenarios:

• Bone regeneration and socket preservation — verifying that graft substitutes resorb at a rate matched to new bone formation, avoiding both premature collapse and long-term residual particles.
• GBR and GTR membrane development — confirming that barrier membranes remain intact long enough to exclude soft tissue ingrowth (typically several weeks) and then resorb without eliciting adverse reactions.
• Absorbable suture qualification — establishing tensile strength retention and mass loss profiles consistent with the wound healing timeline in oral mucosa.
• Resorbable fixation devices — defining the mechanical retention window for plates, screws, and pins used in maxillofacial surgery.
• Tissue engineering scaffolds — matching scaffold degradation kinetics to cell infiltration, vascularization, and matrix deposition rates.
• Regulatory submissions — providing the degradation chapters of technical files for FDA 510(k) and PMA submissions, EU MDR technical documentation, NMPA registrations under the GB/T 16886 series, and other national market approvals.
• Design change and equivalence evaluation — demonstrating that modifications to polymer grade, ceramic ratio, manufacturing process, or sterilization method do not adversely alter degradation behavior.
• Shelf-life and stability programs — correlating in vivo performance with real-time and accelerated aging data for finished device expiry assignment.

FAQ

How long does a degradation test take?

Real-time in vitro studies commonly run from several weeks up to 12 months or longer, depending on the expected resorption period of the material. Accelerated studies at elevated temperatures can deliver comparative data within one to three months, but regulatory reviewers generally expect real-time data to support final claims. In vivo degradation studies per ISO 10993-6 typically extend from 4 weeks to 26 weeks or more depending on the animal model and material.

Which standards govern degradation testing of oral absorbable materials?

The core standards are ISO 10993-13 for polymeric devices, ISO 10993-14 for ceramics, ISO 10993-15 for metals, ISO 10993-9 for the overall framework, and ISO 10993-17 for toxicological risk assessment of degradation products. ASTM F1635 and ASTM F2902 provide detailed guidance for absorbable polymeric devices, ISO 15814 addresses PLA/PLGA implants, ISO 13779 covers hydroxyapatite materials, and the GB/T 16886 series applies to submissions in China.

What degradation medium should be used?

The medium should reflect the intended clinical environment. PBS or Tris-HCl buffer at pH 7.4 is the standard baseline for hydrolytically degraded polymers, artificial saliva or SBF may be appropriate for direct oral-contact devices, and enzyme-supplemented media (for example, collagenase for collagen membranes) are used when enzymatic degradation dominates. ISO 10993-14 additionally requires acidic and alkaline extremes for ceramic materials.

How many specimens and time points are required?

A typical design uses three to five replicate specimens per time point with a minimum of four to six time points spanning the full degradation curve, including time zero. Sacrificial sampling at each interval is standard because most characterization methods are destructive. Accredited third-party laboratories tailor the protocol to the material class, device geometry, and target market.

Is in vitro degradation testing sufficient, or is in vivo testing needed?

In vitro testing is the primary method for quantifying degradation products and kinetics under controlled conditions, and it feeds the toxicological risk assessment. However, because in vivo resorption involves cellular activity, enzymatic action, and vascular clearance that cannot be fully replicated in vitro, confirmatory in vivo implantation studies per ISO 10993-6 are frequently requested by regulators for novel absorbable dental materials or those with long resorption times.

How does sterilization affect degradation testing?

Radiation-based sterilization (gamma or e-beam) can reduce initial molecular weight and accelerate subsequent hydrolysis, while ethylene oxide exposure may leave residues that alter local chemistry. Degradation studies should therefore be performed on specimens in their final sterilized condition, and sterilization effects should be documented as part of the design rationale.